A delayed benefit shows why using early lab results alone does not give a full picture of long-term cardiovascular effects
Plateaus are data, not defeat
In March 2025, she posts a detailed video about her experience with Mounjaro, hormone therapy, and Midi Health, explicitly disclosing her investment
The medication represents an advancement in treating obesity as a modifiable risk factor for heart disease, joining established treatments for high blood pressure, diabetes, and high cholesterol
RGR = ln (W 2 ) ln (W 1 )/T 2 T 1 [where, W 2 = Final plant dry biomass at time T 2 , and W 1 = Final plant dry biomass at time T 1 ]
Research from clinical trials indicates that these medications can help individuals lose 15-25% of their body weight over 68-72 weeks when combined with healthy habits